Edit
called TrialReach
http://trialreach.com/Last activity: 27.07.2016
Active - Reference to Antidote
Employees: 201-500
Total raised: $17.81M
Founded date: 2008
Funding Rounds 3
| Date | Series | Amount | Investors |
| 05.02.2015 | Series B | $13.5M | Smedvig Ca... |
| 08.05.2013 | - | $3.11M | - |
| 27.10.2011 | - | $1.2M | - |
Mentions in press and media 13
| Date | Title | Description |
| 27.07.2016 | Big Health raises $12 million for sleep-focused employee wellness app, Sleepio | Big Health, the UK digital health startup behind sleep health app Sleepio, has raised $12 million (9.5 million pounds) in a round led by Octopus Ventures. Kaiser Permanente Ventures also contributed to the round, as did Omada Health CEO Sea... |
| 21.02.2015 | Guest Post: Lloyd Price of Zesty Discusses the UK’s Healthtech Revolution | This article was originally posted on the Tech City UK website. Is Healthtech poised to break through in London in 2015 like Fintech in 2013? We hear the opinion of Lloyd Price, Co-founder of Zesty Yes, 2015 is set to be the most exciting... |
| 06.02.2015 | TrialReach — сервис для поиска медицинских испытаний Статьи редакции | Каждый день редакция ЦП выбирает один свежий зарубежный стартап, вызвавший резонанс в профессиональном сообществе, и рассказывает о нём читателям. Сегодня в «Идеях для бизнеса» — TrialReach, сервис для поиска и подачи заявок на участие в ме... |
| 06.02.2015 | Funding roundup - week ending 2/06/15 | AnyPerk, Pley, Guardant, HomeLight, SketchDeck, DesignCrowd, Taboola, Qumulo, BucketFeet, Skimlinks Seed stage SketchDeck, a full graphic design on demand service, raised $500,000 from Y Combinator, Dharmesh Shah, Michael Siebel and other a... |
| 05.02.2015 | TrialReach raises $13.5m series B led by Smedvig Capital | TrialReach raises $13.5m series B led by Smedvig Capital 05-02-2015 Funding will fuel TrialReach’s clinical trial platform growth and expansion into the U.S. TrialReach, the world’s largest provider of clinical trial information, today anno... |
| 05.02.2015 | TrialReach Raises $13.5M Series B To Match Patients To Clinical Trials | TrialReach is an interesting startup on a number of fronts. Firstly, the company is based in London but does most of its business in the “fast-moving” U.S. healthcare market. Secondly, and more significantly, it’s using technology to solve ... |
| 05.02.2015 | TrialReach Raises $13.5M in Series B Financing | TrialReach, a London, U.K.-based provider of clinical trial information, raised $13.5M in Series B financing. The round was led by Smedvig Capital with participation from existing investors Amadeus Capital Partners and Octopus Investments. ... |
| 05.02.2015 | TrialReach raises $13.5m series B led by Smedvig Capital | Funding will fuel TrialReach’s clinical trial platform growth and expansion into the U.S. TrialReach, the world’s largest provider of clinical trial information, today announced it has raised a $13.5M Series B financing round led by Smedvig... |
| 19.02.2014 | myTomorrows Raises $2.2M For Platform To Give Patients Access To Development-Stage Drugs | myTomorrows is a Dutch startup that wants to disrupt the way patients with unmet medical needs access development-stage treatments — drugs that are still undergoing clinical trials and working there way through a lengthy regulatory approval... |
| 28.01.2014 | Patient-centric clinical trial recruitment tools want to eliminate [medical] language barrier | Reg4all or Registries for All, takes a more indirect approach to clinical trials. It was developed by Genetic Alliance with some backing from Sanofi to provide a matchmaking service for patients and clinical trials. Participants can control... |
Show more